Â¥
7.57
Jul 4
New Key Statistics Module, Z-Score and F-Score
SZSE:002252 Key Ratios
Market Cap ¥ M | 50,306.29 |
Enterprise Value ¥ M | 45,647.14 |
P/E(ttm) | 27.33 |
PE Ratio without NRI | 26.38 |
Forward PE Ratio | -- |
Price/Book | 1.65 |
Price/Sales | 6.23 |
Price/Free Cash Flow | 34.09 |
Price/Owner Earnings | 32.08 |
Payout Ratio % | 0.10 |
Revenue (TTM) ¥ M | 7,957.00 |
EPS (TTM) ¥ | 0.28 |
Beneish M-Score | -2.47 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -7.60 |
EV-to-EBIT | 20.14 |
EV-to-EBITDA | 20.14 |
PEG | -- |
Shares Outstanding M | 6,645.48 |
Net Margin (%) | 22.84 |
Operating Margin % | 28.99 |
Pre-tax Margin (%) | 28.48 |
Quick Ratio | 2.51 |
Current Ratio | 4.05 |
ROA % (ttm) | 5.69 |
ROE % (ttm) | 6.07 |
ROIC % (ttm) | 7.28 |
Dividend Yield % | 0.39 |
Altman Z-Score | 14.30 |
SZSE:002252 Number of Guru Trades
SZSE:002252 Volume of Guru Trades
Gurus Latest Trades with SZSE:002252
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002252 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Shanghai RAAS Blood Products Co Ltd Insider Transactions
No Available Data